SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC lung)

Maastricht Radiation Oncology

Status: Completed

Conditions: Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01855191

SDC Lung

Details and patient eligibility

About

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

Full description

All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling.

Follow up at five time points:

• 2 weeks after RT
• 3 months after RT
• 6 months after RT
• 12 months after RT
• 24 months after RT

At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.

Enrollment: 864 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients planned for curatively intended radiotherapy or postoperative radiotherapy
• Recurrent disease

Exclusion criteria

• All patients planned for palliative radiotherapy

Trial design

864 participants in 2 patient groups

Standard

Standard + saliva collection